Literature DB >> 23124952

Using self-organizing map (SOM) and support vector machine (SVM) for classification of selectivity of ACAT inhibitors.

Ling Wang1, Maolin Wang, Aixia Yan, Bin Dai.   

Abstract

Using a self-organizing map (SOM) and support vector machine, two classification models were built to predict whether a compound is a selective inhibitor toward the two Acyl-coenzyme A: cholesterol acyltransferase (ACAT) isozymes, ACAT-1 and ACAT-2. A dataset of 97 ACAT inhibitors was collected. For each molecule, the global descriptors, 2D and 3D property autocorrelation descriptors and autocorrelation of surface properties were calculated from the program ADRIANA.Code. The prediction accuracies of the models (based on the training/ test set splitting by SOM method) for the test sets are 88.9 % for SOM1, 92.6 % for SVM1 model. In addition, the extended connectivity fingerprints (ECFP_4) for all the molecules were calculated and the structure-activity relationship of selective ACAT inhibitors was summarized, which may help find important structural features of inhibitors relating to the selectivity of ACAT isozymes.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23124952     DOI: 10.1007/s11030-012-9404-z

Source DB:  PubMed          Journal:  Mol Divers        ISSN: 1381-1991            Impact factor:   2.943


  38 in total

1.  Classification of Aurora-A Kinase Inhibitors Using Self-Organizing Map (SOM) and Support Vector Machine (SVM).

Authors:  Liyu Wang; Zhi Wang; Aixia Yan; Qipeng Yuan
Journal:  Mol Inform       Date:  2011-01-21       Impact factor: 3.353

2.  A selective ACAT-1 inhibitor, K-604, suppresses fatty streak lesions in fat-fed hamsters without affecting plasma cholesterol levels.

Authors:  Mami Ikenoya; Yasunobu Yoshinaka; Hideyuki Kobayashi; Katsumi Kawamine; Kimiyuki Shibuya; Fumiyasu Sato; Kimio Sawanobori; Takuya Watanabe; Akira Miyazaki
Journal:  Atherosclerosis       Date:  2006-07-03       Impact factor: 5.162

Review 3.  Inhibitors of acyl-coenzyme a: cholesterol acyltransferase.

Authors:  Akira Miyazaki; Tomoko Kanome; Takuya Watanabe
Journal:  Curr Drug Targets Cardiovasc Haematol Disord       Date:  2005-12

4.  Inhibition of acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) prevents dietary cholesterol-associated steatosis by enhancing hepatic triglyceride mobilization.

Authors:  Heather M Alger; J Mark Brown; Janet K Sawyer; Kathryn L Kelley; Ramesh Shah; Martha D Wilson; Mark C Willingham; Lawrence L Rudel
Journal:  J Biol Chem       Date:  2010-03-15       Impact factor: 5.157

5.  A classification study of human β₃-adrenergic receptor agonists using BCUT descriptors.

Authors:  Ming Hao; Yan Li; Yonghua Wang; Shuwei Zhang
Journal:  Mol Divers       Date:  2011-05-31       Impact factor: 2.943

Review 6.  Isoform-specific inhibitors of ACATs: recent advances and promising developments.

Authors:  Taichi Ohshiro; Hiroshi Tomoda
Journal:  Future Med Chem       Date:  2011-12       Impact factor: 3.808

7.  6-mercaptopurine inhibits atherosclerosis in apolipoprotein e*3-leiden transgenic mice through atheroprotective actions on monocytes and macrophages.

Authors:  Thijs W H Pols; Peter I Bonta; Nuno M M Pires; Iker Otermin; Mariska Vos; Margreet R de Vries; Marco van Eijk; Jeroen Roelofsen; Louis M Havekes; Paul H A Quax; André B P van Kuilenburg; Vivian de Waard; Hans Pannekoek; Carlie J M de Vries
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-04-22       Impact factor: 8.311

8.  Molecular cloning and functional expression of human acyl-coenzyme A:cholesterol acyltransferase cDNA in mutant Chinese hamster ovary cells.

Authors:  C C Chang; H Y Huh; K M Cadigan; T Y Chang
Journal:  J Biol Chem       Date:  1993-10-05       Impact factor: 5.157

9.  Mass-production of human ACAT-1 and ACAT-2 to screen isoform-specific inhibitor: a different substrate specificity and inhibitory regulation.

Authors:  Kyung-Hyun Cho; Sojin An; Woo-Song Lee; Young-Ki Paik; Young-Kook Kim; Tae-Sook Jeong
Journal:  Biochem Biophys Res Commun       Date:  2003-10-03       Impact factor: 3.575

10.  Selective inhibition of acyl-CoA:cholesterol acyltransferase 2 isozyme by flavasperone and sterigmatocystin from Aspergillus species.

Authors:  Kent Sakai; Satoshi Ohte; Taichi Ohshiro; Daisuke Matsuda; Rokuro Masuma; Lawrence L Rudel; Hiroshi Tomoda
Journal:  J Antibiot (Tokyo)       Date:  2008-09       Impact factor: 2.649

View more
  5 in total

1.  In silico prediction of ROCK II inhibitors by different classification approaches.

Authors:  Chuipu Cai; Qihui Wu; Yunxia Luo; Huili Ma; Jiangang Shen; Yongbin Zhang; Lei Yang; Yunbo Chen; Zehuai Wen; Qi Wang
Journal:  Mol Divers       Date:  2017-08-02       Impact factor: 2.943

2.  Identification of potential ACAT-2 selective inhibitors using pharmacophore, SVM and SVR from Chinese herbs.

Authors:  Lian-Sheng Qiao; Xian-Bao Zhang; Lu-di Jiang; Yan-Ling Zhang; Gong-Yu Li
Journal:  Mol Divers       Date:  2016-06-21       Impact factor: 2.943

3.  Consensus models for CDK5 inhibitors in silico and their application to inhibitor discovery.

Authors:  Jiansong Fang; Ranyao Yang; Li Gao; Shengqian Yang; Xiaocong Pang; Chao Li; Yangyang He; Ai-Lin Liu; Guan-Hua Du
Journal:  Mol Divers       Date:  2014-12-16       Impact factor: 2.943

4.  Screening of cytochrome P450 3A4 inhibitors via in silico and in vitro approaches.

Authors:  Xiaocong Pang; Baoyue Zhang; Guangyan Mu; Jie Xia; Qian Xiang; Xia Zhao; Ailin Liu; Guanhua Du; Yimin Cui
Journal:  RSC Adv       Date:  2018-10-10       Impact factor: 4.036

5.  Unsupervised genome-wide recognition of local relationship patterns.

Authors:  Neda Zamani; Pamela Russell; Henrik Lantz; Marc P Hoeppner; Jennifer Rs Meadows; Nagarjun Vijay; Evan Mauceli; Federica di Palma; Kerstin Lindblad-Toh; Patric Jern; Manfred G Grabherr
Journal:  BMC Genomics       Date:  2013-05-24       Impact factor: 3.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.